D-0167-2023 Class III Terminated

Recalled by Intersect ENT, Inc. — Menlo Park, CA

FDA drug recall D-0167-2023 was initiated by Intersect ENT, Inc. on Jan 4, 2023 and is designated Class III. Reason for recall: Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months. The recall status is terminated (terminated Aug 21, 2024). Affected quantity: 9898 pouches.

Recall details

Product Type
Drugs
Report Date
Jan 25, 2023
Initiation Date
Jan 4, 2023
Termination Date
Aug 21, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9898 pouches

Product description

SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025, NDC 10599-003-01.

Reason for recall

Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.

Distribution pattern

Nationwide

Code information

Lot #s: 10111003, Exp 12/31/2022; 10203002, Exp 01/31/2023; 10302002, 10325001, Exp 02/28/2023; 10519001, 10526002, Exp 04/30/2023; 10602002, Exp 05/31/2023; 10819004, Exp 09/30/2023; 21092101, 21111901, Exp 10/31/2023; 21110402, Exp 12/31/2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0167-2023
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Intersect ENT, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0167-2023. Report a data issue: hello@regdatalab.com.